The MRC Protein Phosphorylation and Ubiquitylation Unit (PPU) at the University of Dundee is a world class research institute, in which researchers make use of cutting-edge technology to study cellular and molecular mechanisms that underpin a number of diseases such as neurological disorders, cancer and hypertension. Scientists at the MRC PPU tackle major long-term questions, with a focus on the regulation of eukaryotic cell biology and human disease by protein phosphorylation and ubiquitylation. The MRC PPU operates as a focal point between leading life scientists, pharmaceutical companies and clinicians, to get a deeper understanding of diseases and how to treat them. The MRC PPU is part of the the School of Life Sciences (SLS) of the University of Dundee (UNIVDUN) and therefore benefits from having both a university and research institute environment. The SLS is repeatedly voted one of 'the best places for a life scientist to work' by The Scientist magazine.
Magdalena was born in Poland and completed her MSc and BSc degrees at the University of Warsaw. Her research interest focus mostly on cell signaling pathways. During her bachelor studies, she investigated the role of interleukin 4 in adipose cell differentiation towards muscles. Her master thesis focused on the influence of tyrosine kinase pathway inhibition together with antihypertensive drugs on renal cancer cells. In the future, Magdalena would like to contribute to the discovery of new potential drug targets and to the development of new pharmaceuticals and treatments by pursuing a research career in the life science industry. She is joining the UbiCODE programme as a member of Yogesh Kulathu’s research group at the MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee, where she will study how proteins are degraded in the nucleus.